U.S. clinicians, so far, have been able to cope with the ongoing medical isotope shortage through various strategies, but many say they are worried that the situation will worsen when a Dutch reactor shuts down later this month for repairs. Combined medical isotope production at the reactors in Belgium, France and South Africa will be between 30% and 40% of normal total production while the Dutch and Canadian reactors are offline, estimates Robert Atcher, SNM past-president and isotope committee chairman.

Related Summaries